Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Expert Opinion on Drug Safety|March 24, 2025
An updated safety review of Hidradenitis Suppurativa treatment optionsRuggero Cascio Ingurgio, Luciano Ibba, Angela Alfano, et al.
Dermatology and Therapy|April 24, 2026
Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World StudyPaola Facheris, Francesco Piscazzi, Giovanni Fiorillo, et al.
Dermatology Reports|July 3, 2024
Atypical facial pustular folliculitis by Klebsiella pneumoniae: a case reportMario Valenti, Andrea Cortese, Paola Facheris, et al.
Journal of Cutaneous Pathology|November 27, 2019
Specific infiltrate of Hodgkin lymphoma at site of cellulitis mimicking secondary cutaneous involvementPaola Facheris, Mario Valenti, Giulia Pavia, et al.
Dermatology and Therapy|March 11, 2025
Chronic Hand Eczema (CHE): A Narrative ReviewGioele Ghezzi, Costanza Falcidia, Giovanni Paolino, et al.
Clinical, Cosmetic and Investigational Dermatology|March 18, 2024
Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic ReviewLuciano Ibba, Luigi Gargiulo, Carlo Alberto Vignoli, et al.
Dermatologic Therapy|April 15, 2020
Brodalumab: A new way to inhibit IL-17 in psoriasisPaola Facheris, Mario Valenti, Giulia Pavia, et al.
Dermatologic Therapy|November 25, 2021
Anti-IL17 and anti-IL23 biologic drugs for scalp psoriasis: A single-center retrospective comparative studyAlessandra Narcisi, Mario Valenti, Andrea Cortese, et al.
Pageof 8